-
Freyr Supported FDA EUA for a COVID-19 Oral Pill
January 2022New Jersey, January 11, 2022: Freyr, a leading global Regulatory solutions and services provider supported a top American Multinational Pharmaceutical company for a US FDA Emergency Use Authorization...
-
ELEMED Featured Freyr as the “Best Supplier to the Industry”
December 2021New Jersey, December 17, 2021- Freyr is excited and elated to announce that it is bestowed with the “Best Supplier to the Industry” award by ELEMED for the year 2021. Represented by Vardhini S...
-
Darnitsa Becomes the First Ukrainian-Based Pharmaceutical Company to Implement Freyr’s AMS with Integrated GlobalVision Verify Tool
December 2021New Jersey, Dec 15, 2021: Freyr, a leading global Regulatory solutions and service provider, is pleased to announce the partnership with Darnitsa, a Ukrainian-based pharmaceutical company, offering...
-
Freyr Announces Successful Submission of a Complex Application through SUGAM
December 2021New Jersey, December 13, 2021 - Freyr Solutions, announces successful submission of a complex Application to the Drugs Controller General of India (DCGI). The submission was made through an online...
-
ACQ5 Honored Freyr with Three “Gamechangers 2021 Global Awards” in the Pharma and Lifesciences Space
December 2021New Jersey, December 01, 2021 – Freyr Solutions, a leading global Regulatory solutions and services provider, got rewarded in three (03) categories in the “ACQ5 Gamechangers...
-
Freyr Completed 40 PDE/ADE Reports for Ophthalmic and Otic products
September 2021New Jersey, September 23, 2021- Freyr, a leading global Regulatory solutions and services provider, is pleased to announce the feat of completing 40+ Permitted Daily Exposure (PDE) reports for a...
-
GHP Awards 2021 Honored Freyr for ‘Innovative Global Regulatory Services and Solutions for Life Sciences’
September 2021New Jersey, September 2, 2021 – Freyr Solutions, a leading global Regulatory solutions and services provider, has been honored for ‘Innovative Global Regulatory Services and Solutions for Life...
-
Freyr Completes 1500+ PDE Reports in Three (3) Years
May 2021New Jersey, May 18, 2021- Freyr, a leading global Regulatory solutions and services provider, is pleased to announce the feat of completing 1500+ Permissible Daily Exposure (PDE) reports. The feat...
-
Freyr Obtains US FDA Approval for a Client’s First-Ever NDIN
November 2020New Jersey – November 11, 2020: Freyr, a leading global Regulatory solutions and services provider, announced successful submission and approval of a New Dietary Ingredient Notification (NDIN) to the...
-
Freyr - One of the First Few Companies to Submit SPM Pilot to Health Canada
October 2020Princeton, NJ - October 29, 2020: Freyr solutions, a leading global Regulatory solutions and services provider announces successful completion of its first Structured Product Monograph (SPM)...
-
Freyr Successfully Submits NCE-1 (ANDA) to the USFDA For Crystal Pharmaceutical (Suzhou) Co., Ltd
July 2020New Jersey - July 8, 2020: Freyr, a leading global Regulatory solutions and services provider, announced the successful submission of NCE-1 (ANDA) to the USFDA on behalf of Crystal Pharmaceutical (...
-
Freyr Launches Covid-19 Web Platform for Manufacturers
June 2020New Jersey – June 23, 2020: Freyr – a leading global Regulatory solutions and services company, announces the launch of a powerful web platform for Covid-19 driven with real-time information for...
